Latest filing published 01 May 2026 for Arovella Therapeutics Limited. Read the official filing
Only one filing by David John Williams Date of appointment 28 April 2026 Part 1 - Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust is known so far (1 May 2026): a transaction, in Arovella Therapeutics Limited. That is too little to draw conclusions. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.